Extracorporeal membrane oxygenator as a bridge to successful surgical repair of bronchopleural fistula following bilateral sequential lung transplantation: a case report and review of literature
- Nouman U Khan†1Email author,
- Mohamed Al-Aloul†1,
- Noman Khasati†1,
- Ali Machaal†1,
- Colm T Leonard†1 and
- Nizar Yonan†1
© Khan et al; licensee BioMed Central Ltd. 2007
Received: 02 April 2007
Accepted: 05 June 2007
Published: 05 June 2007
Lung transplantation (LTx) is widely accepted as a therapeutic option for end-stage respiratory failure in cystic fibrosis. However, airway complications remain a major cause of morbidity and mortality in these patients, serious airway complications like bronchopleural fistula (BPF) are rare, and their management is very difficult.
A 47-year-old man with end-stage respiratory failure due to cystic fibrosis underwent bilateral sequential lung transplantation. Severe post-operative bleeding occurred due to dense intrapleural adhesions of the native lungs. He was re-explored and packed leading to satisfactory haemostasis. He developed a bronchopleural fistula on the 14th post-operative day. The fistula was successfully repaired using pericardial and intercostal vascular flaps with veno-venous extracorporeal membrane oxygenator (VV-ECMO) support. Subsequently his recovery was uneventful.
The combination of pedicled intercostal and pericardial flaps provide adequate vascular tissue for sealing a large BPF following LTx. Veno-venous ECMO allows a feasible bridge to recovery.
Airway complications remain a major cause of morbidity and mortality after lung transplantation . While the overall incidence of such complications can be as high as 15%, bronchopleural fistulas (BPF) are fortunately very uncommon. This is, however, a disastrous event after lung transplants. Most cases occur early after transplantation, are extremely difficult to treat and are associated with a high mortality. We report successful surgical repair of bronchopleural fistula in the donor bronchus employing a Levitronix Centrimag® [Waltham, Massachusetts]-based veno-venous extracorporeal membrane oxygenator support with 6 days bridge to recovery.
A 47-year-old man with end-stage respiratory failure due to cystic fibrosis underwent bilateral sequential lung transplantation. The donor was a 48-year-old male who died of sub-arachnoid haemorrhage and was ventilated for 24 hours. The pulmonary evaluation was normal, with a pO2 of 59.7 kPa on FiO2 of 1, normal chest X-ray and bronchoscopic appearance. The retrieval was performed with the standard technique, using both ante-grade and retro-grade flush of low potassium dextran solution (Perfadex®). The transplantation was carried out through a clamshell incision. Explantation of the native lungs was protracted and difficult due to dense intra-pleural adhesions. Implantation was performed with the standard technique. The right lung was implanted first, using continuous 3/0 polypropylene sutures for the bronchial anastomosis (end-end-technique), continuous 4/0 polypropylene sutures for the pulmonary vein to left atrial anastomosis, and continuous 5/0 polypropylene sutures for the pulmonary arterial anastomosis. According to the standard technique, the donor bronchus was left as short as possible, and the sutures were applied almost level with the upper lobe division. The left lung was implanted in a similar fashion. The overall ischemia time was 6 hours and 8 minutes for the right lung, and just over 8 hours for the left. The patient had a persistent left-sided superior vena cava, which was carefully dissected away from the pulmonary vessels. Despite measures to reduce bleeding, including the use of intra-operative veno-arterial extra-corporeal membrane oxygenation (ECMO) instead of cardiopulmonary bypass, generous use of blood product replacement therapy and full dose of aprotinin, he bled excessively from the pleural bed. Because of persistent bleeding, the chest was packed at the end of operation with skin closure. He was given routine immunosuppressive therapy including induction with rabbit anti-thymocyte globulin (RATG) and intravenous methyl prednisolone (three doses of 125 mg each at 8 hourly intervals, followed by a tapering regimen from 1 mg/kg/day) according to our standard unit protocol.
During the immediate post-operative period, he was re-explored twice due to bleeding. After correction of the abnormal coagulation with fresh frozen plasma, cryoprecipitate and platelet transfusions, he was also given 3.6 mg of recombinant activated factor VII. Eventually, the bleeding settled and the chest was closed on the 4th post-operative day. Subsequent surveillance bronchoscopies showed slough at the bronchial anastomoses with thick purulent secretions in the distal airways bilaterally. A percutaneous tracheostomy was performed on the 9th post-operative day due to prolonged requirement for ventilatory support and to aid in bronchial toilet, and the patient weaned successfully from mechanical ventilation. The bronchoalveolar aspirate revealed Pseudomonas aeruginosa and Candida parapsilosis, which were treated appropriately.
The patient did very well. ECMO was maintained for 6 days after repair of the bronchopleural fistula and regular surveillance bronchoscopy demonstrated intact anastomoses and satisfactory right main bronchus calibre. No further heparin was given, and the activated clotting time (ACT) was kept between 140 and 160 seconds. There were no bleeding problems. Pressure controlled ventilation was maintained using the single lumen tracheostomy tube. The peak airway pressures were gradually increased to 20–25 mm Hg at the time of removal of ECMO. The oxygen delivered via ECMO was adjusted according to the arterial blood gas results, and was successfully reduced to 40% within 4 days. After the first 48 hours, the ECMO flow rate was maintained at 2.5 L/min, with 3200 RPM. Prior to discontinuation of ECMO, the patient was relying on his lung for oxygenation with no oxygen given through the oxygenator. Both the cannulae were successfully removed with application of pressure on the site and without any problems. He was discharged home 59 days after the original transplant, with an FEV1 of 2.01 litres and a normal flow volume loop and he remains well 9 months later.
Previous reports of bronchial dehiscence following lung transplantation.
Total no. of lung transplants
Total no. of anastomoses
Total no. of airway complications
No. of bronchial dehiscence
Kshettry V R 
102 (77 SLT, 25 BSLT)
Alvarez A 
100 (29 SLT, 61 BSLT)
Ruttmann E 
81 (29 SLT, 48 BSLT)
Van de Wauwer C 
232 (102 SLT, 130 BSLT)
29 (8.0 %)*
Several factors have been implicated in the aetiology of bronchopleural fistula following lung transplantation. Bronchial ischaemia is considered the major contributor, as the bronchial circulation is lost during harvest and the viability of the donor bronchus is initially dependent upon retrograde low-pressure collaterals derived from the pulmonary artery . Our case had a bleeding problem post-operatively, and required re-exploration and packing. The pressure of the packs or clots might have exacerbated ischaemia of the donor bronchus i.e. pressure necrosis of the right main bronchus distal to the anastomosis. In addition, we used activated factor VII to correct coagulopathy. The use of activated factor seven had been associated with the development of acute myocardial infarction  but an association with the development of bronchial ischaemia and dehiscence following lung transplantation has not been reported.
To prevent ischemia of the donor bronchus, several anastomotic techniques have been described, such as shortening the donor bronchus , end-end or telescopic anastomosis, direct revascularization of the donor bronchial arteries and wrapping a vascularised omental or internal mammary artery flap around the bronchial anastomosis . As the donor bronchial segment is dependent on retrograde pulmonary blood flow, it seemed logical that donor ischemia would be minimized by keeping the donor bronchus as short as possible. This has been supported by clinical experience with double lung transplantation with bilateral bronchial rather than tracheal anastomoses . We also keep the shortest possible length of the donor bronchus. Initially the telescoping technique was thought to prevent bronchial anastomotic complications ; however recent evidence suggests that the end-end anastomosis technique is associated with significantly less airway complications . Similarly the use of running sutures in the membranous part and interrupted stitches for the cartilaginous portion has conventionally been advocated; however, recent evidence has shown that the single running suture technique with monofilament sutures used for bronchial anastomosis in lung transplantation provides optimal results with regards to early and long-term bronchial healing . We have used continuous running sutures as a standard for bronchial anastomosis at our institution for over 10 years. This is the first case of bronchial disruption in our experience, involving the membranous portion of the donor bronchus, distal to the anastomosis.
Direct bronchial artery revascularization has been described by some authors [12, 13], achieving complete revascularization in up to 60% of patients. However, due to the added complexity and equal incidence of complication rates, there is currently little evidence to support its use. Wrapping the bronchial anastomosis with omentum or other vascularized pedicles has demonstrated reestablishment of collateral circulation to the donor bronchus . However, omentopexy adds substantial complexity and morbidity to lung transplantation due to the addition of a laparotomy and an obligatory diaphragmatic defect. This technique is not infallible and has not been advocated by some investigators . Other vascularized flaps have been employed to obviate omentopexy ; however, some investigators have shown satisfactory bronchial healing without any vascularized coverage of the bronchus . We do not utilise the technique of anastomotic wrapping in our centre.
The perioperative use of steroid therapy was believed to be deleterious for the bronchial anastomosis , however recent evidence suggests that low to moderate doses of pre- and post-operative steroids do not affect bronchial healing . Our patient was not on maintenance prednisolone prior to transplant.
Infections, particularly due to aspergillus, have been associated with impaired bronchial healing  and a higher rate of airway complications have been reported in patients with septic lung disease (cystic fibrosis) . Our case showed evidence of bronchial infection with Pseudomonas aeruginosa and Candida parapsilosis, which might have contributed to the development of BPF.
Management of BPF in lung transplant recipients is very challenging with limited published experience in the English literature. With few exceptions, most reports pertain to management of post pneumonectomy BPF in lung cancer patients. The approach will depend on a number of factors such as the size and site, time between surgery and presentation, whether or not empyema is present and the patient's general health status. The key points of BPF management include empyema drainage and infection control, fistula closure and reinforcement, and pleural space obliteration. Surgical closure techniques include direct stump closure with flap reinforcement, trans-sternal bronchial closure, thoracoplasty with or without extra-thoracic chest wall muscle transposition and video-assisted thoracoscopy. Kirk et al described the surgical management of bronchial dehiscence which occurred despite using an omental flap in a case of lung transplantation for pulmonary fibrosis . They excised the necrotic bronchus and re-anastomosed the distal healthy bronchus using interrupted polypropylene sutures. They constructed the second anastomosis at the level of bifurcation of the donor left main bronchus, to achieve perfusion from pulmonary bronchial collaterals. They also wrapped a vascular pericardial flap around the anastomosis. We utilised pedicled pericardial flap to close the BPF, and the intercostal flap to reinforce the repair.
In high-risk surgical patients, endoscopic repair may serve as the only therapeutic option. In 1977 Ratliff et al reported the first successful endo-bronchial management of BPF using tissue glue and a lead shot . Since then, many reports using different devices have appeared. These include ethanol silver nitrate, cyanoacrylate compounds, coils, lead plugs, balloons, fibrin or tissue glue, antibiotics, gel foam, spigots, and autologous blood patch. Recently Mora et al described a series of 18 patients, including 1 post-lung transplant, treated endoscopically for BPF . The fistula was 9 mm in size, and appeared 30 days post-transplant. It was successfully closed by 2 injections of fibrin sealant (Tissucol®) through the catheter of the fiberoptic bronchoscope without any complications. In our case, the size of the fistula prohibited bronchoscopic approach to treatment.
Borro et al described a case of spontaneous closure of bronchial fistula to the mediastinum in a heart-lung transplant patient . They suggested that since the bronchial perforation in their patient occurred in the 3rd post-operative week, full cicatrisation of the mediastinum helped limit the spread of infection and contributed to the favourable outcome obtained by adequate antibiotic and physiotherapeutic treatment.
Achieving adequate ventilation is often difficult in these patients, particularly if single lung ventilation has to be achieved. The use of differential ventilation using double-lumen endotracheal tube and jet ventilation or cardiopulmonary bypass has been the traditional options . We utilised veno-venous ECMO, which is now an established tool in our centre for managing patients with primary graft failure after lung transplant. With improved technology it is now possible to use this device with minimal heparinization, thereby preventing any bleeding complications [23, 24]. Our patient had severe intraplerual adhesions, causing bleeding following explantation of the native lungs. Therefore, based on the available evidence at that time , we decided to use intra-operative veno-arterial ECMO to avoid full heparinization otherwise necessary with conventional cardiopulmonary bypass. However, we encountered bleeding problems post-operatively, requiring blood products as well as activated factor VII. Recently published data also suggests that intra-operative use of ECMO may be associated with increased risk of bleeding .
During the first 24 hours following the repair of BPF, the patient required full ECMO support with 100% oxygen delivery as the aim was to rest the lungs and reduce the pressure on the repair. Afterwards, the ECMO requirement diminished. We, however, used ECMO for 6 days as we believed that healing of the repaired bronchus would be sufficient around that time. During this period we carried out frequent flexible bronchoscopic assessments. At day 5, the anastomosis appeared to be healing well.
To our knowledge this is the first reported case for using ECMO as a bridge for successful surgical repair of BPF following lung transplantation utilising pericardial and intercostal flaps. We have used the Levitronix Centrimag device, which was maintained without any anticoagulation for six days after repair of the fistula (ACT was kept between 140–160 seconds). There were no clots in the system on full examination when it was finally removed.
In summary, the combination of an intercostal and a pedicled pericardial flap provides adequate robust vascularised tissue for sealing a large BP fistula following lung transplantation. Veno-venous ECMO allows a feasible bridge to recovery.
- Kshettry VR, Kroshus TJ, Hertz MI, Hunter DW, Shumway SJ, Bolman RM: Early and late airway complications after lung transplantation: incidence and management. Ann Thorac Surg. 1997, 63 (6): 1576-1583. 10.1016/S0003-4975(97)83852-0.View ArticlePubMedGoogle Scholar
- Egan TM, Detterbeck FC, Mill MR, Paradowski LJ, Lackner RP, Ogden WD, Yankaskas JR, Westerman JH, Thompson JT, Weiner MA: Improved results of lung transplantation for patients with cystic fibrosis. J Thorac Cardiovasc Surg. 1995, 109 (2): 224-34; discussion 234-5. 10.1016/S0022-5223(95)70383-7.View ArticlePubMedGoogle Scholar
- Alvarez A, Algar J, Santos F, Lama R, Aranda JL, Baamonde C, Lopez-Pujol J, Salvatierra A: Airway complications after lung transplantation: a review of 151 anastomoses. Eur J Cardiothorac Surg. 2001, 19 (4): 381-387. 10.1016/S1010-7940(01)00619-4.View ArticlePubMedGoogle Scholar
- Ruttmann E, Ulmer H, Marchese M, Dunst K, Geltner C, Margreiter R, Laufer G, Mueller LC: Evaluation of factors damaging the bronchial wall in lung transplantation. J Heart Lung Transplant. 2005, 24 (3): 275-281. 10.1016/j.healun.2004.01.008.View ArticlePubMedGoogle Scholar
- Van De Wauwer C, Van Raemdonck D, Verleden GM, Dupont L, De Leyn P, Coosemans W, Nafteux P, Lerut T: Risk factors for airway complications within the first year after lung transplantation. Eur J Cardiothorac Surg. 2007, 31 (4): 703-710. 10.1016/j.ejcts.2007.01.025.View ArticlePubMedGoogle Scholar
- Shennib H, Massard G: Airway complications in lung transplantation. Ann Thorac Surg. 1994, 57 (2): 506-511.View ArticlePubMedGoogle Scholar
- Peerlinck K, Vermylen J: Acute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitor. Thromb Haemost. 1999, 82 (6): 1775-1776.PubMedGoogle Scholar
- Pinsker KL, Koerner SK, Kamholz SL, Hagstrom JW, Veith FJ: Effect of donor bronchial length on healing: a canine model to evaluate bronchial anastomotic problems in lung transplantation. J Thorac Cardiovasc Surg. 1979, 77 (5): 669-673.PubMedGoogle Scholar
- Dubois P, Choiniere L, Cooper JD: Bronchial omentopexy in canine lung allotransplantation. Ann Thorac Surg. 1984, 38 (3): 211-214.View ArticlePubMedGoogle Scholar
- Noirclerc MJ, Metras D, Vaillant A, Dumon JF, Zimmermann JM, Caamano A, Orsoni PC: Bilateral bronchial anastomosis in double lung and heart-lung transplantations. Eur J Cardiothorac Surg. 1990, 4 (6): 314-317. 10.1016/1010-7940(90)90208-H.View ArticlePubMedGoogle Scholar
- Aigner C, Jaksch P, Seebacher G, Neuhauser P, Marta G, Wisser W, Klepetko W: Single running suture--the new standard technique for bronchial anastomoses in lung transplantation. Eur J Cardiothorac Surg. 2003, 23 (4): 488-493. 10.1016/S1010-7940(03)00018-6.View ArticlePubMedGoogle Scholar
- Couraud L, Baudet E, Martigne C, Roques X, Velly JF, Laborde N, Dubrez J, Clerc F, Dromer C, Vallieres E: Bronchial revascularization in double-lung transplantation: a series of 8 patients. Bordeaux Lung and Heart-Lung Transplant Group. Ann Thorac Surg. 1992, 53 (1): 88-94.View ArticlePubMedGoogle Scholar
- Pettersson G, Norgaard MA, Arendrup H, Brandenhof P, Helvind M, Joyce F, Stentoft P, Olesen PS, Thiis JJ, Efsen F, Mortensen SA, Svendsen UG: Direct bronchial artery revascularization and en bloc double lung transplantation--surgical techniques and early outcome. J Heart Lung Transplant. 1997, 16 (3): 320-333.PubMedGoogle Scholar
- Fell SC, Mollenkopf FP, Montefusco CM, Mitsudo S, Kamholz SL, Goldsmith J, Veith FJ: Revascularization of ischemic bronchial anastomoses by an intercostal pedicle flap. J Thorac Cardiovasc Surg. 1985, 90 (2): 172-178.PubMedGoogle Scholar
- Khaghani A, Tadjkarimi S, al-Kattan K, Banner N, Daly R, Theodoropoulos S, Madden B, Yacoub M: Wrapping the anastomosis with omentum or an internal mammary artery pedicle does not improve bronchial healing after single lung transplantation: results of a randomized clinical trial. J Heart Lung Transplant. 1994, 13 (5): 767-773.PubMedGoogle Scholar
- Taghavi S, Marta GM, Lang G, Seebacher G, Winkler G, Schmid K, Klepetko W: Bronchial stump coverage with a pedicled pericardial flap: an effective method for prevention of postpneumonectomy bronchopleural fistula. Ann Thorac Surg. 2005, 79 (1): 284-288. 10.1016/j.athoracsur.2004.06.108.View ArticlePubMedGoogle Scholar
- Auteri JS, Jeevanandam V, Sanchez JA, Marboe CC, Kirby TJ, Smith CR: Normal bronchial healing without bronchial wrapping in canine lung transplantation. Ann Thorac Surg. 1992, 53 (1): 80-3; discussion 83-4.View ArticlePubMedGoogle Scholar
- Lima O, Cooper JD, Peters WJ, Ayabe H, Townsend E, Luk SC, Goldberg M: Effects of methylprednisolone and azathioprine on bronchial healing following lung autotransplantation. J Thorac Cardiovasc Surg. 1981, 82 (2): 211-215.PubMedGoogle Scholar
- Kirk AJ, Conacher ID, Corris PA, Ashcroft T, Dark JH: Successful surgical management of bronchial dehiscence after single-lung transplantation. Ann Thorac Surg. 1990, 49 (1): 147-149.View ArticlePubMedGoogle Scholar
- Ratliff JL, Hill JD, Tucker H, Fallat R: Endobronchial control of bronchopleural fistulae. Chest. 1977, 71 (1): 98-99.View ArticlePubMedGoogle Scholar
- Mora G, de Pablo A, Garcia-Gallo CL, Laporta R, Ussetti P, Gamez P, Cordoba M, Varela A, Ferreiro MJ: [Is endoscopic treatment of bronchopleural fistula useful?]. Arch Bronconeumol. 2006, 42 (8): 394-398. 10.1157/13091648.View ArticlePubMedGoogle Scholar
- Borro JM, Ramos F, Vicente R, Sanchis F, Morales P, Caffarena JM: Bronchial fistula to the mediastinum in a heart-lung transplant patient. Eur J Cardiothorac Surg. 1992, 6 (12): 674-5; discussion 676. 10.1016/1010-7940(92)90193-2.View ArticlePubMedGoogle Scholar
- Ko WJ, Chen YS, Lee YC: Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations. Artif Organs. 2001, 25 (8): 607-612. 10.1046/j.1525-1594.2001.025008607.x.View ArticlePubMedGoogle Scholar
- Oto T, Rosenfeldt F, Rowland M, Pick A, Rabinov M, Preovolos A, Snell G, Williams T, Esmore D: Extracorporeal membrane oxygenation after lung transplantation: evolving technique improves outcomes. Ann Thorac Surg. 2004, 78 (4): 1230-1235. 10.1016/j.athoracsur.2004.03.095.View ArticlePubMedGoogle Scholar
- Bittner HB, Binner C, Lehmann S, Kuntze T, Rastan A, Mohr FW: Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations. Eur J Cardiothorac Surg. 2007, 31 (3): 462-7; discussion 467. 10.1016/j.ejcts.2006.11.050.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.